Opening a GP clinic in Singapore, decoded.
The family doctor sits on the most durable demand in Singapore — private GPs handle about 80% of all primary-care visits, in a country that became a super-aged society in 2026. And yet the solo clinic is being squeezed from three sides at once: corporate chains buying up independents, a free-market fee war in saturated heartland clusters, and a national scheme — Healthier SG — that hands GPs sticky recurring revenue while quietly gutting the drug margin that kept them afloat. Here is the picture the incorporation-firm blogs skip.
~S$150–400k
realistic all-in to open
~1.2M
enrolled in Healthier SG (~half eligible)
~70%
reported fall in GP drug margin under the formulary
2,493
private GP clinics (MOH, 2023)
The MOAT Score: is a GP clinic worth building?
Before the details, our one-number read. The MOAT Score grades a sector's economic quality on the value-investing lens of Graham, Buffett and Munger — four pillars (Margin, Operating moat, Appetite, Treadmill), each out of 25. At 61/100 (C), a GP clinic sits below its sibling the dental clinic — same statutory licence, but thinner, more squeezed margins, a doctor-supply moat that is weakening rather than widening, and a heavier price-war-and-policy treadmill. The demand, though, is exceptional.
Needs a real edge
Only with a real edge.
How the score is built
The MOAT Score sums four pillars — each scored 0–25 — from the value-investing lens of Graham, Buffett and Munger. No black box: here is the working.
Margin
12/25Does the average operator actually keep money — real net margin and return on the capital tied up?
This sector: thinner and more squeezed than dental. Consult fees are a free market (the SMA fee guideline was withdrawn in 2007SourceCCCS / SMAThe Competition Commission ruled the SMA Guideline on Fees anti-competitive; GP pricing has been an open free market ever since. after the competition regulator's ruling) and crushed by insurer panels, while the dispensing margin is collapsing under Healthier SG. A listed GP pure-play nets ~1.4%SourceAlliance Healthcare FY2025, SGX, 2025S$1.1m net profit on S$77.1m revenue, FY to 30 Jun 2025.; diversified Raffles Medical ~9.2%.
Buffett 1979 — “a high earnings rate on equity capital… without undue leverage”; 1986 owner earnings.
Operating moat
14/25Pricing power and a durable competitive advantage — can a typical operator raise prices and have customers shrug?
This sector: the same statutory licence as dental (HCSA + SMC) — but unlike dentistry, the doctor-supply moat is weakening: SMC's recognised overseas-school list grew 103 → 120SourceMOH / SMC recognised-school announcements, 2024–2026 in two years. The real GP moat is the new Healthier SG enrolment lock-in plus the 2030SourceMOH White Paper on Healthier SGFrom 1 July 2030 every Healthier SG clinic must have a doctor on the Family Physicians Register. Family Physician requirement, CHAS panel and records — offset by open pricing and clustering.
Buffett, FCIC 2010 — pricing power is “the single most important decision”; 1991 franchise; 2007 moat.
Appetite
22/25Demand durability — steady, recession-resistant repeat demand vs fragile, discretionary or faddish.
This sector: among the most durable demand we cover: private GPs handle ~80%SourceBMC Health Services Research, 2025 of primary-care visits in a super-aged societySourceMOH, COS debate, Mar 2026, and the state is actively pushing chronic care into private GP via capitation. Non-discretionary and recession-resistant.
Graham, Security Analysis Ch.2 — inherent stability “derives from the character of the business”.
Treadmillinverted · less is better
13/25Capital intensity and structural drag — rent, churn, fashion, discounting. Scored inverted: less treadmill, more points.
This sector: lighter on capital than dental (no chairs or lead-lined rooms — fit-out runs ~S$150–400k), but heavier on structural drag: record heartland rents, a free-market fee war, the insurer-panel squeeze, the collapsing drug margin, and a new policy-dependency and admin load from Healthier SG.
Buffett 2007 — “the worst sort of business… requires significant capital… Think airlines.”
M + O + A + T, out of 100
The MOAT Score is a transparent SGAI judgement on a sector’s economic quality through a value-investing lens — not a verdict on any individual business, and not a comment on an owner-operated livelihood (a sector can score low on capital returns yet work as a job).
The read: the safest demand in Singapore, squeezed from three sides
Start with what makes general practice unusual. Like a dental clinic, a GP clinic is a licensed trade, not a shop — you cannot open one without a doctor registered with the Singapore Medical Council and an HCSA licence. That is a real moat in the Buffett sense. And the demand sitting behind it is about as durable as demand gets: people fall ill regardless of the economy, private GPs carry roughly 80% of all primary-care visits, and Singapore crossed into “super-aged” territory in 2026, with more chronic disease every year. On paper, this should be a wonderful business.
Here is the twist that makes it harder than dentistry. The one input you cannot operate without — a registered doctor — is being made more abundant, not less. Where dentistry is tightening foreign-dentist supply with a 2029 qualifying exam, the SMC has been widening the doctor pipeline: its list of recognised overseas medical schools grew from 103 to 120 in just two years (2024–2026), and local intake keeps rising to meet the ageing wave. So the GP moat is not doctor scarcity. It is something newer and more conditional.
That something is Healthier SG. Since July 2023, residents enrol with a single family doctor, and the funding model has tilted from fee-per-visit toward capitation — a recurring payment per enrolled patient for managing their long-term health. For a clinic, that is a genuine switching-cost moat: a subscription relationship, not a transaction. Almost 1.2 million Singaporeans — about half the eligible population — had enrolled by early 2025, and more than a thousand GPs signed up. This is the closest thing a Singapore GP has ever had to recurring revenue.
But the same scheme is squeezing the old economics. Healthier SG steers prescribing onto a whitelisted-drug formulary, and GPs interviewed in a 2025 peer-reviewed study reported the dispensing margin that historically cross-subsidised their low consult fees had “plunged — not just by 10–20%, but by 70%.” Stack that on top of the two older squeezes — insurer third-party administrators clawing back consult fees (net fees reported as low as S$2–10), and a free-market fee war in over-clustered heartland estates — and you understand why solo doctors are selling to chains. The moat is real; the margin under it is thin and getting thinner. The game is throughput, a sticky enrolled panel, and a higher-value service layer — not the licence, which you'll get.
The fee floor a GP can't escape
A private GP is fenced in from below. The state holds polyclinic visits cheap, insurers run flat-fee promos, and a public scheme prices common-illness consults at S$10 — so the heartland consult is anchored low, while the doctor's own hourly worth as a locum sits far above it.
- Scheme / promo flat consultS$12
PHPC S$10 respiratory; insurer "$13 GP" promos — the floor
- Polyclinic consult (citizen, subsidised)S$17
state-subsidised — the benchmark patients anchor to
- Typical heartland private consultanchorS$33
before meds; many clusters compete down to S$30–35
- Private GP consult (higher end, ex-meds)S$60
after-hours / non-heartland
- Locum GP — per hourS$110
the doctor’s own market rate, S$80–130/hr — the opportunity cost
Source: SGAI synthesis of CHAS/scheme rates, polyclinic fees, SG GP price surveys + SMA News locum-rate reporting, 2024–2026 (indicative; consult-only, ex-medication)
The map: 2,493 GP clinics, the corporate roll-up — and the “market size” number is junk
The honest, primary number: as of 2023, Singapore had 2,493SourceMOH Health Facilities statistics, 2023 private GP clinics, against just 26 polyclinics — and that ~80/20 private-to-public split is the structural fact of primary care here. Ignore the dollar “market size” reports entirely: the figures you will see quoted — Singapore's health & wellness market at US$17bnShaky figure — treat with cautionIMARC / aggregatorThis is the whole health-and-wellness market, and other aggregators put national health expenditure near US$44bn by 2030. Neither measures GP-clinic revenue. There is no clean published figure for the GP-clinic market., national health spending heading to US$44bnShaky figure — treat with cautionaggregator forecastEntire health system — hospitals, pharma, devices, government subsidies. Not GP-clinic revenue. — are the entire health system, not GP-clinic revenue. There is no credible published number for the Singapore GP-clinic market; anyone quoting one is conflating hospitals and pharma with the family doctor down the road. What is real and structurally important: the market is fragmenting upward — corporate chains are buying up the independents.
2,493
private GP clinics
MOH Health Facilities, 2023 (primary)
~80%
of primary-care visits are private GP
vs ~20% polyclinic — BMC 2025
17,582
registered doctors (end-2024)
up ~50% in a decade — SMC AR2025
20.7%
of citizens are 65+ (2025)
→ ~23.9% by 2030 — the demand tailwind
The tailwind: a super-aged society
Unlike fashion-exposed sectors, GP demand rides a slow, certain demographic wave. The share of citizens aged 65+ has climbed for a decade and keeps going — and older patients carry far more chronic disease, the exact work Healthier SG is pushing toward private GPs.
2025—1 in 5 citizens aged 65+ — Singapore is officially "super-aged" (2026)
2030—projected ~1 in 4 — a structural, not cyclical, driver
Source: population.gov.sg / SingStat, 2025 (citizen 65+ share; 2015, 2025, 2030 reported/projected; 2020 indicative). Note: the resident 65+ share is lower (~18.8% in 2025).
The players: the corporatisation squeeze
This is the story that defines GP today. A wave of PE- and strategic-backed chains is rolling up solo clinics — for the procurement scale, the shared back-office, and a locum pool the lone doctor can't match. The trend is now politically visible: an MP filed a parliamentary question on corporate-chain consolidation of small practices in March 2026, to which MOH replied it does not even monitor it. For a founder, the chains are both your competition and your most likely exit.
Who's buying up Singapore's GP clinics
| Player | Model | SG clinics | Ownership / backing | Signal |
|---|---|---|---|---|
| Raffles Medical GroupSGX-listed, integrated | Clinics + hospital + insurance | ~80+ | Listed (SGX: BSL) | The public proxy: S$765.3m rev, ~9.2% net (FY2025) |
| Healthway MedicalOne of the largest networks | GP + dental + specialist + screening | 130+ | OUE + Gateway block (delisted 2023) | Taken private at ~S$240m, Nov 2023 |
| Parkway Shenton (IHH)Primary-care arm of IHH | GP / corporate / panel network | ~50 | IHH — Mitsui ~33%, Khazanah ~26% | Global strategic capital behind heartland GP |
| Fullerton HealthCorporate-health led | GP + corporate health + panel | ~30 | Far East Drug (maj.) + RRJ + Mitsubishi | Recapitalised ~S$390m (2022); ~US$1bn valuation (2024) |
| Alliance HealthcareListed GP pure-play (SGX: MIJ) | Owned GP clinics + ~1,900 panel | ~16–17 owned | Listed, founder-controlled | Rev S$77.1m but net just S$1.1m (~1.4%), FY2025 |
| The independent solo clinicThe bulk of the 2,493 | 1 doctor, owner-operated | most | Self-funded | Wins on niche, panel & relationship — or sells in |
Raffles Medical Group
SGX-listed, integrated
- Model
- Clinics + hospital + insurance
- SG clinics
- ~80+
- Ownership / backing
- Listed (SGX: BSL)
- Signal
- The public proxy: S$765.3m rev, ~9.2% net (FY2025)
Healthway Medical
One of the largest networks
- Model
- GP + dental + specialist + screening
- SG clinics
- 130+
- Ownership / backing
- OUE + Gateway block (delisted 2023)
- Signal
- Taken private at ~S$240m, Nov 2023
Parkway Shenton (IHH)
Primary-care arm of IHH
- Model
- GP / corporate / panel network
- SG clinics
- ~50
- Ownership / backing
- IHH — Mitsui ~33%, Khazanah ~26%
- Signal
- Global strategic capital behind heartland GP
Fullerton Health
Corporate-health led
- Model
- GP + corporate health + panel
- SG clinics
- ~30
- Ownership / backing
- Far East Drug (maj.) + RRJ + Mitsubishi
- Signal
- Recapitalised ~S$390m (2022); ~US$1bn valuation (2024)
Alliance Healthcare
Listed GP pure-play (SGX: MIJ)
- Model
- Owned GP clinics + ~1,900 panel
- SG clinics
- ~16–17 owned
- Ownership / backing
- Listed, founder-controlled
- Signal
- Rev S$77.1m but net just S$1.1m (~1.4%), FY2025
The independent solo clinic
The bulk of the 2,493
- Model
- 1 doctor, owner-operated
- SG clinics
- most
- Ownership / backing
- Self-funded
- Signal
- Wins on niche, panel & relationship — or sells in
The data point that should sober every founder: Alliance Healthcare
Alliance is the only listed Singapore GP pure-play — so its audited numbers are the cleanest window into group GP economics. In FY2025 it turned over S$77.1 million in revenue and kept just S$1.1 million in net profit — a margin of roughly 1.4%. A scaled, listed operator with ~16 owned clinics and a 1,900-clinic panel still runs on a razor-thin bottom line. Whenever you read “GP clinics make 30–40% margins,” remember that is a gross figure from a foreign textbook — not the Singapore reality of consult-fee compression and a collapsing drug margin.
The customer: who pays — and how much of it is the government's money
A GP's patient base is acute illness, medical certificates, vaccinations and minor procedures — but the strategic prize is chronic-disease management, which polyclinics have historically dominated (they handle ~45% of chronic visits despite only ~20% of total primary care). Healthier SG and the Chronic Disease Management Programme are explicitly designed to shift that work, and its funding, to private GPs. So the funding mix — how much of the bill is cash, insurer, CHAS subsidy, MediSave and capitation — increasingly decides the P&L.
How a private GP bill actually gets paid
Indicative funding mix for a heartland-leaning private GP clinic. The headline: a large and growing slice is government-railed (CHAS, MediSave, Healthier SG capitation) — which brings volume and recurring revenue, but also drug-formulary control and scheme dependency.
- Cash / private insurance (acute, MCs, screening)45%walk-in acute illness, medical certificates, vaccinations, corporate panels — the bread and butter
- CHAS subsidy (citizens, common & chronic)24%becoming a CHAS clinic is the #1 heartland patient channel — Blue card up to S$18.50/common visit
- MediSave (chronic — CDMP)18%chronic-condition visits & meds; withdrawal limits rising to S$700/$1,000 from Jan 2027
- Healthier SG capitation (enrolled patients)13%recurring per-patient payment — but MOH has not disclosed the rate
Source: SGAI synthesis of CHAS subsidy tables (chas.sg, 2026), MediSave/CDMP rules (MOH, 2026), Healthier SG descriptions + the BMC 2025 primary-care study. Shares are indicative of the funding structure, not a measured per-clinic split.
The capitation lock-in — and its catch
Healthier SG gives a clinic a sticky, recurring relationship: each resident enrols with one family doctor, and the clinic is paid an ongoing risk-adjusted fee to manage their health. That is the moat. The catch: MOH has not publicly disclosed the per-patient capitation rate, and GPs interviewed in 2025 said the payment “often exceeded” by the cost of meeting the protocols. You are locking in revenue you can't fully price — plan conservatively.
The cluster trap: rent without pricing power
Because MOH does not plan where clinics open, heartland estates over-cluster and compete on price. In June 2025 a single HDB clinic unit in Tampines drew a record S$52,188/monthSingle source — not independently corroboratedHDB tender, via The Online Citizen, Jun 2025Reported by a single outlet; the winning clinic kept consult fees at only S$30–35. HDB tender results are verifiable. rent bid — while the winning clinic kept its consult fee at S$30–35 to stay competitive. High rent, no pricing power: the cluster trap in one number.
The economics: the licence is cheap, the squeeze is real
A GP clinic is cheaper to build than a dental one — no chairs, no lead-lined rooms — so the all-in cost runs roughly S$150,000–400,000+, dominated by the medical fit-out (~S$300–500 per square foot), equipment, a rental deposit and working capital. The HCSA licence is trivial (S$360 per service, two years). But the operating economics are tighter than the internet suggests. Three lines do the damage: the doctor's own time (a real cost — the S$80–130/hr they could earn as a locum), the heartland rent, and a dispensing margin that is being gutted by the Healthier SG formulary. What's left is thin and under active compression — not the “30–40%” folk figure.
All-in cost to open a GP clinic
Medical fit-out (the bulk, ~S$300–500 psf), equipment and signage, plus a rental deposit and several months of working capital. The “S$80–120k” floors online exclude a proper fit-out. Buying an existing clinic avoids fit-out capital but adds a six-figure goodwill fee for the patient panel.
Source: SGAI build from SG medical fit-out + rent benchmarks (Medinex, contractbuilders, 2025); OCBC Medi-Starter loans up to S$300k (folk floor flagged)
Where the GP dollar goes
A typical SG heartland-leaning clinic, modelled per S$100 of collections — counting the owner-doctor's own time at its true locum-equivalent cost (so this is economic profit, not a salary dressed up as profit). The doctor, the rent and the shrinking drug margin are the swing lines.
- Doctor’s own time (locum-equivalent cost)−38%62% left
the S$80–130/hr the owner-doctor forgoes; a real economic cost, not free · SMA News locum rates — modelled as a cost
- Support staff + CPF−16%46% left
nurse / clinic assistant / reception; CPF 17% on top · Medinex SG salary benchmarks 2025
- Rent + occupancy−12%34% left
heartland void-deck units bid up hard (S$52k Tampines record, 2025) · SGAI estimate / SG listings
- Medicines / dispensing (net of squeeze)−14%20% left
the line that historically cross-subsidised low fees — now compressed ~70% on whitelisted drugs · BMC Health Services Research 2025 (qualitative)
- Consumables + vaccines−5%15% left
SG clinic benchmarks / SGAI calc
- Other fixed (CMS, licences, utilities, insurance, marketing)−9%6% left
What the owner actually keeps
Verdict: A thin 6% — survivable, not comfortable; one bad assumption flips it negative.
Illustrative model. Singapore publishes no per-clinic GP P&L; the consult-fee, drug-margin and locum lines draw on SMA News + BMC Health Services Research (2025) and are modelled as ranges. Counting the owner-doctor's pay as a cost means a busy owner who works the chairs themselves keeps the doctor line too — but the economic margin on the business itself is thin. Not financial advice.
GP / family clinic
Would a value investor own the average operator here?
A value investor would want a GP clinic only with a real edge. The licence and the super-aged demand are genuinely good — but the average solo clinic faces free-market fee competition, an insurer-panel squeeze, a collapsing drug margin and a weakening doctor-supply moat. The winners build a sticky Healthier SG panel and a higher-value service layer.
Consult fees are a free market squeezed by insurer panels and scheme floors; the price-maker work is screening, aesthetics and corporate panels — for fully-registered doctors.
Buffett, FCIC 2010 — pricing power is “the single most important decision”
A statutory licence (SMC + HCSA) you cannot operate without, plus a NEW capitation/enrolment lock-in — but the doctor-supply side is loosening (103→120 recognised schools), so the moat is holding, not widening.
Buffett 1991 — a franchise “not subject to price regulation”; 2007 — an enduring moat
Lighter fit-out than dental, so capital recovers faster — but thin operating margins (a listed pure-play nets ~1.4%) cap the return on it.
Buffett 1979 — a high earnings rate on capital, unleveraged
Medical fit-out + equipment, but no chairs or lead-lined rooms; materially lighter than a dental clinic.
Buffett 2007 — the worst business needs much capital, earns little
Non-discretionary health need on a super-aged tailwind; ~80% of primary care runs through private GPs.
Graham, Security Analysis Ch.2 — inherent stability is qualitative
A sticky enrolled Healthier SG panel for recurring revenue; a higher-value layer (chronic care, screening, aesthetics if fully registered, corporate/house-call); a well-chosen, less-clustered catchment; and the discipline to count the doctor's own time as a cost. The Family Physician qualification matters more after 2030.
Assessment uses the value-investing lens on SG GP unit economics (2024–2026), with Raffles Medical and Alliance Healthcare (SGX) as public proxies. A lens on economic quality, not a verdict on an owner-operated livelihood — a GP clinic can be a fine job even where the business margin is thin. Many SG cost ratios are modelled where no clean figure exists, flagged where used.
Model your own clinic — watch the drug-margin squeeze move your break-even:
Break-even patients / day
52
just to cover rent, staff & a fair doctor’s wage
Monthly net (after doctor pay)
−S$5,224
Throughput
45/day
tight
Verdict: Below break-even — at this throughput the clinic does not cover the fixed base AND a fair wage for the doctor. This is the new-clinic reality until the panel builds, and what pushes many solo GPs to sell to a chain.
Illustrative model on SG benchmarks (2024–2026). Singapore publishes no per-clinic GP P&L; the net consult fee, dispensing margin and the ~70% drug-margin squeeze are drawn from SMA News and BMC Health Services Research (2025) and modelled as ranges. The doctor's own pay is counted as a cost (the locum-equivalent they forgo), so “net” is true economic profit, not a salary. A starting frame, not financial advice. Throughput guide: >55/day busy, 38–55 tight, <38 quiet.
How to actually open one (in the order that matters)
Like dentistry, this is a two-track process — register the doctor, license the premises — but with a third track unique to GP: the scheme accreditations (CHAS, CDMP, Healthier SG) that unlock the heartland patients and the recurring revenue. Sequence them so you're not paying rent on a clinic that can't bill the patients walking in.
The approval stack, sequenced
- SMC registration + Practising Certificate — the doctor must be registered to practise. Foreign-trained = conditional (supervised) registration first, and conditionally-registered doctors cannot do aesthetics or more than 20% screening.
- URA change-of-use — the premises must be approved for clinic use (medical use is capped per building). Pre-check the floor area with MOH. Gate 1.
- SCDF fire safety — plans via a Qualified Person → Fire Safety Certificate. Gate 2.
- HCSA Outpatient Medical Service licence — apply via the HALP portal at least 2 months before opening; appoint a Clinical Governance Officer (a fully-registered SMC doctor). S$360 per service / 2 years. MOH targets ~30 working days.
- HSA + NEA — an HSA licence to hold/dispense medicines (GP clinics dispense on-site), and an NEA radiation licence (~S$155) if you run an X-ray.
- CHAS → CDMP → Healthier SG — get CHAS- and Chronic Disease Management Programme-accredited, then apply for Healthier SG via the Primary Care Digital Services portal and join a Primary Care Network. This is where the heartland volume and recurring revenue live.
The trap most founders miss: the advertising rules — and the 2030 clock
The marketing playbook that works for an e-commerce SME is largely off-limits for a Singapore clinic. Under the SMC Ethical Code and the HCSA advertising regulations, medical advertising must be factual and verifiable — no testimonials, no before-and-after claims, no inducements or comparative “best/cheapest” messaging. Compliant growth runs on credentials, education, organic reputation and your CHAS/Healthier SG panel. Two clocks to watch: the old PHMCA regime was repealed in December 2023 (any guide citing it, or the “LEAP” portal, is out of date); and from 1 July 2030, every Healthier SG clinic must have a doctor on the Family Physicians Register — so if recurring capitation revenue is your plan, line up the Graduate Diploma in Family Medicine or a partner well before then.
Where a new practice actually wins
The commodity heartland acute-and-MC clinic is the saturated, price-warred, thin-margin core. The defensible plays escape the cup — they own recurring revenue, a higher-value layer, or a catchment the chains under-serve. Note the binding constraints throughout: the 2030 Family Physician requirement, the whitelisted-drug margin, and the bars on aesthetics/screening for conditionally-registered doctors.
Healthier SG chronic-care capture
The recurring-revenue gap. The state is explicitly moving chronic care from polyclinics (which hold ~45% of chronic visits) into private GPs via capitation. A clinic built to enrol, retain and manage a chronic panel wins the stickiest revenue a GP has ever had — mind the drug-margin and capitation-rate caveats.
Aesthetics & screening margin layer
The real SG margin phenomenon: many family physicians cross-credential and run GP + aesthetics + executive screening under one roof. It is gated — conditionally-registered doctors are barred from aesthetics and capped at 20% screening — which is exactly what makes it defensible for those who qualify.
House-call / mobile GP for the elderly
A clear ageing-driven gap on the strongest tailwind. Operators (Speedoc, Doctor Anywhere, DCMED) are circling, but supply is thin against the volume of homebound elderly in a super-aged society.
Corporate health & telemedicine panels
A B2B revenue layer beyond walk-ins: pre-employment medicals, occupational health, and insurer/employer panels. Telemedicine needs SMC registration + MOH e-training, but it scales past a single shopfront.
A less-clustered catchment
Saturation is a distribution problem, not a national one — MOH doesn’t plan clinic locations. Maturing BTO towns and under-served pockets beat fighting six clinics in one mature estate. Validate with catchment data; prime void-deck slots are fiercely contested (the S$52k Tampines bid).
Build to sell
The corporate roll-up (Raffles, Healthway, Fullerton, Parkway Shenton, IHH) is a real buyer. A well-systemised clinic with a sticky enrolled panel and clean books isn’t just a job — it’s a sellable asset. Build transferable processes and a Family Physician on staff from the start.
Questions founders ask
How much does it cost to open a GP clinic in Singapore?
Realistically S$150,000–400,000+ all-in for a typical heartland or commercial clinic — materially cheaper than a dental clinic because there are no dental chairs or lead-lined X-ray rooms, but a proper medical fit-out still runs roughly S$300–500 per square foot, plus equipment, a rental deposit and several months of working capital. Online "S$80,000–120,000" floors exclude a real fit-out. The HCSA Outpatient Medical Service licence itself is the cheap part (S$360 per service for two years). Buying an existing clinic instead avoids fit-out capital but adds a six-figure goodwill payment for the patient panel.
Is a GP clinic profitable in Singapore — and should I stay a locum or open my own?
It can be, but not at the "30–40%" margins quoted online — those are gross, before the doctor is paid, and they are US/global figures, not Singapore. The honest Singapore picture: a locum GP earns roughly S$80–130 an hour with zero capital risk but no scale; an owner-GP at high throughput can take home more (operators cite north of S$25,000 a month), but they carry rent, staff, scheme compliance and a shrinking drug margin. The only listed Singapore GP pure-play, Alliance Healthcare, netted about 1.4% on S$77.1m of revenue in FY2025 — a stark reminder of how thin a GP group's bottom line can be. Going solo is a real upside play, but increasingly a rent- and policy-exposed one.
What licences do I need to open a GP / family clinic in Singapore?
Two tracks at once. The doctor must be registered with the Singapore Medical Council (SMC) and hold a valid Practising Certificate. The clinic needs an Outpatient Medical Service licence under the Healthcare Services Act (HCSA) — applied for via the HALP portal at least two months before opening, with a Clinical Governance Officer who is a fully-registered SMC doctor. On top: URA change-of-use, an SCDF Fire Safety Certificate, an HSA licence if you dispense or hold medicines, an NEA radiation licence if you operate an X-ray, and CHAS/CDMP accreditation if you want subsidised heartland patients. The old PHMCA regime was repealed in December 2023 — any guide citing it is out of date.
How do I join Healthier SG as a GP clinic, and do I need to be a Family Physician?
You must first be CHAS- and Chronic Disease Management Programme-accredited, then apply via the Primary Care Digital Services portal and join a Primary Care Network. More than 1,000 GPs (over 1,200 private clinics) have already signed up, and almost 1.2 million Singaporeans — about half the eligible population — were enrolled by March 2025. You do not need to be a registered Family Physician today, but from 1 July 2030 every Healthier SG clinic must have at least one doctor on the Family Physicians Register — so a solo GP without that qualification will need to upskill (via the Graduate Diploma in Family Medicine) or partner to keep the recurring capitation revenue.
Want a report like this for your company or sector?
Tell us what you're trying to figure out. We'll build you a Deep-Context report — the same depth, focused on your business.
About this report. Built with SGAI's Deep-Context Engine — human-directed, AI-accelerated. Figures draw on MOH (incl. the Health Facilities statistics, the HCSA licensing portal, Healthier SG and CHAS/CDMP), the Singapore Medical Council, SingStat / population.gov.sg, SMA News, the 2025 BMC Health Services Research study on Singapore's primary-care reform, and the SGX filings of Raffles Medical and Alliance Healthcare (2025–2026). Singapore publishes no clean per-clinic GP unit economics, and MOH has not disclosed the Healthier SG capitation rate, so several cost lines are modelled ranges — flagged where used — with the listed operators as the public anchors. Verify fees and regulatory steps with each agency before acting; this is not financial, legal or clinical advice.
We're not a grant office — we build AI and intelligence for Singapore SMEs. Talk to us.